PROM1 and glioblastoma: In conclusion, this study has shown that CD133 can regulate the PI3K/Akt and MAPK pathways in GBM, and its silencing results in the arrested cell cycle at the sub-G1 phase, stimulated apoptosis, and inhibited clonogenicity of U87MG cells.